Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies - Takeaways - MDSpire

Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies

  • By

  • Chunxiao Gao

  • Ting Zhang

  • Guangyuan Li

  • Weishan Zhang

  • Honglin Chen

  • Diefei Li

  • Jixuan Xu

  • Mengxue Li

  • Ruihong Wang

  • Yamin Xing

  • Jian Zhan

  • Zhentai Ren

  • Xia Xue

  • Wulong Liang

  • Xiangdong Sun

  • Xiaojuan Zhang

  • Xinfeng Liang

  • Hongqiao Zhan

  • Zisen Zhang

  • Xiufeng Chu

  • July 3, 2026

  • 0 min

Share

  • 1

    The article corrects a mistake regarding the role of chemotherapy in combination therapies for esophageal cancer.

  • 2

    CD8+ T cells are functionally impaired in esophageal cancer due to immune checkpoint molecules and M2-type tumor-associated macrophages.

  • 3

    P-gp inhibitors like Encequidar and MB07133 show promise in overcoming chemoresistance, though trials in esophageal cancer are lacking.

  • 4

    Elevated expression of DNA damage response proteins is linked to chemotherapy resistance in esophageal cancer.

  • 5

    CDK4/6 inhibitors are being explored for their efficacy in esophageal cancer, with ongoing clinical trials for Palbociclib.

Original Source(s)

Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies

  • by Chunxiao Gao, Ting Zhang, Guangyuan Li, Weishan Zhang, Honglin Chen, Diefei Li, Jixuan Xu, Mengxue Li, Ruihong Wang, Yamin Xing, Jian Zhan, Zhentai Ren, Xia Xue, Wulong Liang, Xiangdong Sun, Xiaojuan Zhang, Xinfeng Liang, Hongqiao Zhan, Zisen Zhang, Xiufeng Chu

  • July 3, 2026

Related Content

Malignant peripheral nerve sheath tumor of the ileocecal region: a case report

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

Detection of cancer recurrence from Thai-English electronic medical records using sentence embeddings